Parvovirus Clinical Trials Parvovirus RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer
Condition:   Carcinoma, Pancreatic DuctalIntervention:   Drug: Parvovirus H-1 (H-1PV)Sponsor:   Oryx GmbH & Co. KGRecruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2015 Category: Research Source Type: clinical trials

A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease
Condition:   Sickle Cell DiseaseInterventions:   Other: Blood draw;   Other: Nasopharyngeal washSponsors:   St. Jude Children's Research Hospital;   Novartis Vaccines;   National Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2014 Category: Research Source Type: clinical trials

A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease
Condition:   Sickle Cell DiseaseInterventions:   Other: Blood draw;   Other: Nasopharyngeal washSponsors:   St. Jude Children's Research Hospital;   Novartis Vaccines;   National Heart, Lung, and Blood Institute (NHLBI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2014 Category: Research Source Type: clinical trials